SBRT
Clinical trials for SBRT explained in plain language.
Never miss a new study
Get alerted when new SBRT trials appear
Sign up with your email to follow new studies for SBRT, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New combo therapy targets Hard-to-Treat salivary gland tumors
Disease control Not yet recruitingThis study tests a two-step treatment for people with advanced salivary gland cancer that has come back or spread. First, patients receive a targeted drug that delivers chemotherapy directly to cancer cells. Then, if the disease is stable or only a few new spots appear, they get …
Matched conditions: SBRT
Phase: PHASE2 • Sponsor: Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University • Aim: Disease control
Last updated May 14, 2026 12:06 UTC
-
Triple threat: new hope for liver cancer patients who failed first treatment?
Disease control Not yet recruitingThis study tests a combination of two drugs (Benmelstobart and Anlotinib) plus targeted radiation (SBRT) in 29 adults with liver cancer that has spread to a few spots and stopped responding to initial therapy. The goal is to see if this triple therapy can control the cancer longe…
Matched conditions: SBRT
Phase: PHASE2 • Sponsor: Nanfang Hospital, Southern Medical University • Aim: Disease control
Last updated May 11, 2026 20:39 UTC